| Aksjer | 651,978 Mrd. | — | KO KoAct | 0 | Helsevesen | | 3.8.2023 | 24 121,81 | 8,97 | 37,04 |
KO | Aksjer | 308,329 Mrd. | — | KO KODEX | 0,45 | Helsevesen | FnGuide Bio Index - Benchmark TR Gross | 13.5.2016 | 13 361,03 | 6,85 | 37,93 |
TE | Aksjer | 284,006 Mrd. | — | TE Tiger ETF | 0,40 | Helsevesen | KRX Bio K-New Deal Index - KRW - Benchmark TR Gross | 6.10.2020 | 8 365,47 | 4,73 | 58,48 |
TE | Aksjer | 210,37 Mrd. | — | TE Tiger ETF | 0,40 | Helsevesen | KRX Healthcare - KRW | 15.7.2011 | 50 939,54 | 5,29 | 44,16 |
TE | Aksjer | 102,134 Mrd. | — | TE Tiger ETF | 0,30 | Helsevesen | NASDAQ / Biotechnology | 26.8.2014 | 31 029,93 | 4,93 | 21,41 |
KO | Aksjer | 96,693 Mrd. | — | KO KODEX | 0,09 | Helsevesen | KRX Healthcare - KRW | 28.3.2017 | 23 026,18 | 5,30 | 44,17 |
TE | Aksjer | 91,403 Mrd. | — | TE Tiger ETF | 0,40 | Helsevesen | KOSDAQ 150 Biotech Index - KRW - Benchmark TR Gross | 14.12.2016 | 20 615,98 | 11,86 | 59,10 |
| Aksjer | 82,665 Mrd. | — | KR KB RISE | 0 | Helsevesen | KRX Bio Top 10 Index - KRW - Benchmark TR Gross | 24.12.2024 | 18 228,98 | 9,56 | 68,04 |
TE | Aksjer | 63,216 Mrd. | — | TE Tiger ETF | 0,49 | Helsevesen | Solactive China Biotech Index | 3.12.2020 | 8 395,74 | 4,06 | 36,34 |
KO | Aksjer | 63,055 Mrd. | — | KO KODEX | 0,25 | Helsevesen | S&P Health Care Select Sector | 21.3.2023 | 13 501,85 | 4,99 | 23,29 |
TE | Aksjer | 45,653 Mrd. | — | TE Tiger ETF | 0,45 | Helsevesen | Indxx Global Obesity Treatment Top 2 Plus index - KRW - Benchmark Price Return | 29.2.2024 | 9 975,96 | 9,42 | 20,09 |
KO | Aksjer | 43,772 Mrd. | — | KO KODEX | 0,45 | Helsevesen | iSelect Global Obesity Treatment TOP2 Plus Index - KRW - Benchmark TR Net | 14.2.2024 | 10 533,34 | 5,31 | 13,57 |
SP | Aksjer | 39,243 Mrd. | 14,225 M | SP SPDR | 0,08 | Helsevesen | S&P Health Care Select Sector | 16.12.1998 | 147,19 | 4,92 | 22,89 |
TE | Aksjer | 33,19 Mrd. | — | TE Tiger ETF | 0,40 | Helsevesen | KOSPI 200 Health Care Index - KRW | 23.9.2015 | 21 902,59 | 3,35 | 37,49 |
TE | Aksjer | 31,242 Mrd. | — | TE Tiger ETF | 0 | Helsevesen | S&P Global 1200 Health Care Custom Index - krw - Benchmark TR Gross | 29.6.2016 | 25 575,73 | 0 | 0 |
| Aksjer | 28,17 Mrd. | — | HW Hwabao | 0,60 | Helsevesen | CSI Medical Index Yield - Benchmark TR Gross | 20.5.2019 | 0,33 | 3,08 | 30,88 |
KO | Aksjer | 20,013 Mrd. | — | KO KODEX | 0,25 | Helsevesen | S&P Biotechnology Select Industry | 31.10.2013 | 39 347,54 | 0 | 0 |
EF | Aksjer | 17,607 Mrd. | — | EF E Fund | 0 | Helsevesen | CSI 300 Medical and Health Index - CNY - Benchmark TR Gross | 9.1.2021 | 0,36 | 3,40 | 26,67 |
NH | Aksjer | 17,522 Mrd. | — | NH NH-Amundi | 0 | Helsevesen | | 26.11.2024 | 16 939,32 | 5,97 | 44,18 |
VA | Aksjer | 16,498 Mrd. | 231 887,9 | VA Vanguard | 0,09 | Helsevesen | MSCI US IMI 25/50 Health Care | 26.1.2004 | 272,55 | 5,01 | 23,09 |
| Aksjer | 14,233 Mrd. | — | KO KoAct | 0,50 | Helsevesen | | 11.11.2025 | 10 071,38 | 5,53 | 23,13 |
| Aksjer | 12,08 Mrd. | — | KR KB RISE | 0 | Helsevesen | FnGuide HealthCare Index - KRW - Benchmark TR Net | 23.9.2016 | 18 201,96 | 5,39 | 38,07 |
KI | Aksjer | 9,316 Mrd. | — | KI Kiwoom | 0,49 | Helsevesen | FnGuide Medical AI Index - KRW - Benchmark TR Gross | 28.5.2024 | 14 351,49 | 0 | 0 |
| Aksjer | 8,879 Mrd. | — | AC ACE | 0,30 | Helsevesen | Solactive Global Big Pharma Index - Benchmark Price Return | 19.11.2024 | 12 647,46 | 7,39 | 22,27 |
KO | Aksjer | 8,699 Mrd. | — | KO KODEX | 0 | Helsevesen | | 27.1.2026 | 9 433,95 | 4,22 | 29,48 |
| Aksjer | 8,426 Mrd. | — | AC ACE | 0,45 | Helsevesen | Solactive Eli Lilly Value Chain Index - Benchmark Price Return | 19.11.2024 | 11 981,39 | 3,59 | 23,17 |
IS | Aksjer | 8,048 Mrd. | 1,833 M | IS iShares | 0,44 | Helsevesen | NYSE Biotechnology (TR) | 5.2.2001 | 163,82 | 5,09 | 21,95 |
SP | Aksjer | 7,895 Mrd. | 9,071 M | SP SPDR | 0,35 | Helsevesen | S&P Biotechnology Select Industry | 31.1.2006 | 121,11 | 4,82 | 0 |
TE | Aksjer | 7,089 Mrd. | — | TE Tiger ETF | 0,50 | Helsevesen | FnGuide Medical Device Index - KRX - Benchmark TR Net | 7.11.2018 | 19 854,11 | 2,90 | 23,45 |
BO | Aksjer | 6,371 Mrd. | — | BO Bosera | 0,65 | Helsevesen | Hang Seng Healthcare Index - CNY - Benchmark TR Gross | 18.3.2021 | 0,57 | 2,75 | 12,80 |
CH | Aksjer | 6,166 Mrd. | — | CH ChinaAMC | 0,65 | Helsevesen | Hang Seng Biotech Index - HKD - Benchmark TR Net | 29.9.2021 | 0,75 | 3,00 | 21,32 |
| Aksjer | 6,063 Mrd. | — | MA Maxwealth | 0,60 | Helsevesen | CSI All-Medical Device Index - CNY - Benchmark TR Gross | 22.4.2021 | 0,49 | 2,64 | 31,06 |
KI | Aksjer | 5,711 Mrd. | — | KI Kiwoom | 0,49 | Helsevesen | Solactive Blockbuster Biotech Drugs Index - CNY - Benchmark TR Net | 28.5.2024 | 11 418,81 | 4,40 | 17,99 |
| Aksjer | 5,51 Mrd. | — | KO KoAct | 0,50 | Helsevesen | | 3.9.2024 | 12 147,89 | 4,05 | 18,25 |
| Aksjer | 5,441 Mrd. | — | NI Nippon | 0,19 | Helsevesen | Nifty Pharma Index - INR - Benchmark TR Gross | 2.7.2021 | 17,49 | 4,59 | 31,47 |
NF | Aksjer | 5,258 Mrd. | — | NF NEXT FUNDS | 0,32 | Helsevesen | | 21.3.2008 | 32 540,42 | 1,85 | 20,34 |
| Aksjer | 5,192 Mrd. | — | KR KB RISE | 0,35 | Helsevesen | KEDI Global Obesity Care Industry Top2+ Index - KRW - Benchmark TR Net | 27.2.2024 | 9 393,69 | 8,01 | 19,48 |
TE | Aksjer | 4,915 Mrd. | — | TE Tiger ETF | 0,40 | Helsevesen | TOPIX-17 PHARMACEUTICAL - JPY | 29.6.2016 | 12 065,00 | 0 | 0 |
IC | Aksjer | 4,753 Mrd. | — | IC ICBC | 0 | Helsevesen | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 26.3.2025 | 1,25 | 0 | 0 |
IN | Aksjer | 4,142 Mrd. | — | IN Invesco | 0 | Helsevesen | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 16.10.2024 | 1,52 | 3,45 | 24,62 |
EF | Aksjer | 4,018 Mrd. | — | EF E Fund | 0 | Helsevesen | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 18.3.2025 | 1,18 | 0 | 0 |
GU | Aksjer | 3,769 Mrd. | — | GU Guotai | 0,60 | Helsevesen | CSI Biomedical Index - CNY - Benchmark TR Gross | 18.4.2019 | 0,95 | 0 | 0 |
IS | Aksjer | 3,726 Mrd. | 295 900,4 | IS iShares | 0,40 | Helsevesen | S&P Global 1200 / Health Care -SEC | 13.11.2001 | 92,88 | 4,33 | 21,87 |
IS | Aksjer | 3,363 Mrd. | 2,188 M | IS iShares | 0,38 | Helsevesen | DJ US Select / Medical Equipment | 1.5.2006 | 55,13 | 3,84 | 30,11 |
XT | Aksjer | 3,336 Mrd. | — | XT Xtrackers | 0,25 | Helsevesen | MSCI World Index / Health Care -SEC | 22.11.2010 | 55,78 | 4,49 | 22,03 |
FU | Aksjer | 3,054 Mrd. | — | FU Fullgoal | 0,60 | Helsevesen | Hang Seng Hong Kong Stock Connect Healthcare Index - CNY - Chinese Renminbi - Benchmark TR Gross | 14.6.2023 | 1,29 | 0 | 0 |
IS | Aksjer | 2,943 Mrd. | 824 405,4 | IS iShares | 0,38 | Helsevesen | Russell 1000 Health Care RIC 22.5/45 Capped Index | 12.6.2000 | 61,38 | 4,92 | 23,03 |
FI | Aksjer | 2,847 Mrd. | 188 955,6 | FI Fidelity | 0,08 | Helsevesen | MSCI US IMI 25/50 Health Care | 21.10.2013 | 70,38 | 4,81 | 22,89 |
NH | Aksjer | 2,735 Mrd. | — | NH NH-Amundi | 0,45 | Helsevesen | iSelect K-MediTech Index - KRW - Benchmark Price Return | 21.12.2023 | 9 115,65 | 3,43 | 26,31 |
IS | Aksjer | 2,595 Mrd. | — | IS iShares | 0,15 | Helsevesen | S&P 500 CAPPED 35/20 HEALTH CARE NTR | 20.11.2015 | 11,78 | 5,01 | 23,30 |
GU | Aksjer | 2,351 Mrd. | — | GU Guotai | 0,60 | Helsevesen | CSI Medical Index Yield - Benchmark TR Gross | 24.12.2020 | 0,41 | 3,08 | 30,90 |
| Aksjer | 2,257 Mrd. | — | HW Hwabao | 0 | Helsevesen | Hang Seng SCHK Innovative Drug Select Index - HKD - Benchmark TR Gross | — | 4,67 Mrd. | 0 | 0 |
FT | Aksjer | 2,229 Mrd. | 146 718,5 | FT First Trust | 0,54 | Helsevesen | NYSE Arca Biotechnology Index | 19.6.2006 | 192,42 | 3,25 | 21,80 |
CH | Aksjer | 2,13 Mrd. | — | CH ChinaAMC | 0,75 | Helsevesen | Hang Seng Biotech Index - HKD - Benchmark TR Net | 18.3.2021 | 14,15 | 3,49 | 28,07 |
CH | Aksjer | 2,13 Mrd. | — | CH ChinaAMC | 0,75 | Helsevesen | Hang Seng Biotech Index - HKD - Benchmark TR Net | 18.3.2021 | 14,15 | 3,49 | 28,07 |
PA | Aksjer | 1,836 Mrd. | — | PA Ping An | 0,60 | Helsevesen | CSI Pharmaceutical and Medical Device Innovation Index - CNY - Benchmark TR Gross | 9.6.2021 | 0,35 | 4,13 | 25,07 |
HE | Aksjer | 1,611 Mrd. | — | HE Harvest ETFs | 1,06 | Helsevesen | | 19.11.2014 | 7,10 | 5,01 | 23,83 |
EF | Aksjer | 1,504 Mrd. | — | EF E Fund | 0,20 | Helsevesen | Yield of China Securities Hong Kong Stock Connect Medical and Health Composite Index - CNY - Benchmark TR Net | 19.1.2022 | 1,02 | 2,50 | 20,25 |
AM | Aksjer | 1,49 Mrd. | — | AM Amundi | 0,50 | Helsevesen | MSCI World IMI Virology Select Index - KRW - Benchmark TR Net | 8.6.2022 | 9 937,75 | 2,82 | 14,76 |
IS | Aksjer | 1,462 Mrd. | — | IS iShares | 0,18 | Helsevesen | MSCI Europe Health Care 20/35 Capped Index - EUR | 17.11.2020 | 6,88 | 3,81 | 19,87 |
EF | Aksjer | 1,418 Mrd. | — | EF E Fund | 0,20 | Helsevesen | China Securities Medical Index - CNY - Benchmark TR Gross | 8.7.2021 | 0,39 | 4,40 | 29,55 |
EF | Aksjer | 1,418 Mrd. | — | EF E Fund | 0,20 | Helsevesen | CSI Biotechnology Theme Index - CNY - Benchmark TR Gross | 14.1.2021 | 0,47 | 2,80 | 29,20 |
CA | Aksjer | 1,388 Mrd. | — | CA Cathay | 1,05 | Helsevesen | Solactive Global Genomics Immunology and Medical Revolution Index - Benchmark TR Net | 22.11.2021 | 7,98 | 3,49 | 18,53 |
IS | Aksjer | 1,308 Mrd. | — | IS iShares | 0,46 | Helsevesen | S&P Global 1200 Healthcare Sector Index - AUD | 13.11.2001 | 129,11 | 0 | 0 |
VA | Aksjer | 1,307 Mrd. | 377 540,1 | VA VanEck | 0,36 | Helsevesen | MVIS US Listed Pharmaceutical 25 | 20.12.2011 | 102,24 | 5,01 | 18,89 |
GU | Aksjer | 1,295 Mrd. | — | GU Guotai | 0,60 | Helsevesen | SSE STAR Market Innovative Drug Index - CNY - Benchmark TR Gross | 1.8.2025 | 0,84 | 0 | 0 |
EF | Aksjer | 1,226 Mrd. | — | EF E Fund | 0,20 | Helsevesen | CSI Innovative Drug Industry Index - CNY - Benchmark TR Gross | 3.2.2021 | 0,63 | 3,14 | 28,62 |
XT | Aksjer | 1,13 Mrd. | — | XT Xtrackers | 0,12 | Helsevesen | MSCI USA / Health Care -SEC | 12.9.2017 | 59,11 | 5,21 | 23,49 |
XT | Aksjer | 1,13 Mrd. | — | XT Xtrackers | 0,12 | Helsevesen | MSCI USA / Health Care -SEC | 12.9.2017 | 59,11 | 5,21 | 23,49 |
HA | Aksjer | 1,041 Mrd. | — | HA Harvest | 0,60 | Helsevesen | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 30.7.2025 | 0,82 | 0 | 0 |
IS | Aksjer | 1,01 Mrd. | — | IS iShares | 0,40 | Helsevesen | STOXX Global Breakthrough Healthcare (USD)(NR) | 8.9.2016 | 8,61 | 3,83 | 20,88 |
IS | Aksjer | 994,106 M | — | IS iShares | 0,40 | Helsevesen | STOXX Global Breakthrough Healthcare (USD)(NR) | 8.9.2016 | 8,48 | 3,83 | 20,88 |
IS | Aksjer | 989,832 M | 82 306,48 | IS iShares | 0,38 | Helsevesen | DJ US Select / Pharmaceutical | 1.5.2006 | 85,08 | 4,64 | 21,28 |
GX | Aksjer | 965,57 M | — | GX Global X | 0,59 | Helsevesen | FactSet Japan Bio & Med Technologies Index - JPY - Benchmark TR Net | 21.6.2021 | 1 665,83 | 2,02 | 19,51 |
IS | Aksjer | 891,37 M | — | IS iShares | 0,35 | Helsevesen | NASDAQ / Biotechnology | 19.10.2017 | 8,25 | 0 | 0 |
CS | Aksjer | 856,997 M | — | CS CSOP | 1,50 | Helsevesen | Hang Seng Biotech Index - HKD - Benchmark TR Net | 21.7.2021 | 3,41 | 3,42 | 26,68 |
FT | Aksjer | 856,286 M | 27 126,73 | FT First Trust | 0,61 | Helsevesen | StrataQuant Health Care Index | 8.5.2007 | 107,36 | 2,95 | 17,04 |
AM | Aksjer | 817,302 M | — | AM Amundi | 0,30 | Helsevesen | STOXX Europe 600 / Health Care (Capped) - SS | 17.1.2019 | 146,14 | 3,02 | 20,55 |
AM | Aksjer | 817,302 M | — | AM Amundi | 0,30 | Helsevesen | STOXX Europe 600 / Health Care (Capped) - SS | 17.1.2019 | 146,14 | 3,02 | 20,55 |
| Aksjer | 800,027 M | — | WA Wanjia | 0 | Helsevesen | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 13.9.2024 | 1,46 | 3,45 | 24,62 |
CA | Aksjer | 722,821 M | — | CA Cathay | 0,41 | Helsevesen | Bloomberg Barclays 15+ Year Healthcare Select Index - Benchmark TR Net | 23.4.2019 | 30,38 | 0 | 0 |
IN | Aksjer | 717,884 M | 88 714,95 | IN Invesco | 0,40 | Helsevesen | S&P 500 Equal Weighted / Health Care -SEC | 1.11.2006 | 30,45 | 3,11 | 19,88 |
| Aksjer | 704,19 M | 99 185,66 | PB Portfolio Building Block | 0,13 | Helsevesen | BITA Global Pharma and Biotech Select Index - Benchmark TR Net | 24.11.2025 | 25,02 | 5,27 | 20,40 |
AM | Aksjer | 700,759 M | — | AM Amundi | 0,30 | Helsevesen | MSCI World Index / Health Care -SEC | 19.8.2010 | 462,47 | 7,68 | 29,88 |
IS | Aksjer | 700,447 M | — | IS iShares | 0,46 | Helsevesen | STOXX Europe 600 / Health Care (Capped) - SS | 25.4.2001 | 109,82 | 3,63 | 19,37 |
IS | Aksjer | 698,319 M | 271 605,5 | IS iShares | 0,38 | Helsevesen | DJ US Select / Health Care Providers | 1.5.2006 | 43,25 | 2,20 | 16,35 |
GX | Aksjer | 627,78 M | — | GX Global X | 0,68 | Helsevesen | Solactive China Biotech Index | 25.7.2019 | 66,78 | 4,31 | 40,01 |
GX | Aksjer | 627,724 M | — | GX Global X | 0,68 | Helsevesen | Solactive China Biotech Index | 25.7.2019 | 66,77 | 4,31 | 40,01 |
SP | Aksjer | 620,006 M | — | SP SPDR | 0,30 | Helsevesen | MSCI World Health Care 35/20 Capped Index - Benchmark TR Net | 29.4.2016 | 64,40 | 5,08 | 25,68 |
CS | Aksjer | 591,492 M | — | CS China Southern | 0,65 | Helsevesen | Hang Seng Biotech Index - HKD - Benchmark TR Gross | 17.6.2022 | 1,06 | 2,98 | 21,35 |
IS | Aksjer | 588,191 M | — | IS iShares | 0,18 | Helsevesen | MSCI World Health Care ESG Reduced Carbon Select 20 35 Capped Index - Benchmark TR Net | 17.10.2019 | 7,38 | 4,16 | 22,04 |
SP | Aksjer | 575,183 M | — | SP SPDR | 0,18 | Helsevesen | MSCI Europe Health Care Index - EUR | 5.12.2014 | 218,51 | 3,81 | 19,87 |
SP | Aksjer | 551,981 M | — | SP SPDR | 0,15 | Helsevesen | S&P Health Care Select Sector Daily Capped 25/20 Index | 7.7.2015 | 45,45 | 4,92 | 22,89 |
FU | Aksjer | 524,893 M | — | FU Fullgoal | 0,60 | Helsevesen | CSI Pharmaceutical 50 Index - CNY - Benchmark TR Gross | 16.3.2020 | 0,91 | 0 | 0 |
CH | Aksjer | 518,644 M | — | CH ChinaAMC | 0,60 | Helsevesen | CSI All-Medical Device Index - CNY - Benchmark TR Gross | 23.11.2023 | 0,86 | 2,64 | 31,04 |
IS | Aksjer | 512,011 M | — | IS iShares | 0,66 | Helsevesen | S&P Global 1200 Health Care Hedged to CAD Index - CAD | 12.4.2011 | 67,03 | 0 | 0 |
DI | Aksjer | 508,018 M | 626 389,9 | DI Direxion | 0,96 | Helsevesen | S&P Biotechnology Select Industry | 28.5.2015 | 145,81 | 0 | 0 |
GU | Aksjer | 483,964 M | — | GU Guotai | 0,60 | Helsevesen | CSI Shanghai-Hong Kong-Shenzhen Innovative Pharmaceutical Industry Index - CNY - Benchmark TR Gross | 8.9.2021 | 0,69 | 3,53 | 27,58 |
IN | Aksjer | 419,02 M | — | IN Invesco | 0,40 | Helsevesen | NASDAQ / Biotechnology | 6.11.2014 | 58,93 | 5,11 | 22,17 |
CS | Aksjer | 403,074 M | — | CS China Southern | 0,20 | Helsevesen | CSI Innovative Pharmaceutical Industrial Index - CNY - Benchmark TR Gross | 12.3.2021 | 0,63 | 3,14 | 28,61 |